RESULTS OF PROPHYLACTIC INOCULATION AGAINST PNEUMOCOCCUS IN 12,519 MEN by Cecil, Russell L. & Austin, J. Harold
RESULTS  OF  PROPHYLACTIC  INOCULATION  AGAINST 
PNEUMOCOCCUS  IN  12,519  MEN. 
BY  RUSSELL L.  CECIL,  M.D., 
Major, Medical Reserve Corps, U. S. Army, 
AND J.  HAROLD AUSTIN, M.D., 
Captain, Medical Reserve Corps, U. S. Army. 
(From the Hospital  of The Rockefeller Institute for Medical Research, New York, 
and the Laboratory of the Base Hospital, Camp Upton, New York.) 
(Received  for publication,  April  22,  1918.) 
The  success  of  prophylactic  vaccination  against  typhoid  fever as 
demonstrated by the results obtained in the United States Army  nat- 
urally suggests  the effort to combat  other prevalent and  serious dis- 
eases by the  same  method.  Among  such diseases  pneumonia  easily 
ranks first.  During  the past winter it has been responsible for prob- 
ably 80 per cent of the deaths in the various training  camps  in  this 
country, and though the streptococcus has been the causative agent in 
many  of  these  cases  the pneumococcus has also played a  prominent 
part. 
Animal  experiments have  shown  that  it is  easy to produce active 
immunity to pneumococci by the injection of small doses of dead or- 
ganisms  even in  animals  as  susceptible  as the mouse and rabbit, and 
this  immunity  persists  for  a  considerable  time.  It  is  theoretically 
possible,  therefore,  to  immunize man  to  the  fixed types  of pneumo- 
cocci by injection of dead  cultures. 
The only place to our knowledge where preventive  inoculation against pneumonia 
has been hitherto attempted has been among the workers  in the mines in South 
Africa,  where  the disease  occurs  with great frequency and causes  the death of 
large numbers of native workmen.  The first  inoculations  on a large scale were 
carried out by Sir Almroth Wright (1) in 1911 and 1912.  However, in these ex- 
periments no attention was paid to differences in types of pneumococci and this 
fact renders the interpretation of the results of the inoculations  extremely diffi- 
cult.  In 1913 Dochez and Gillespie (2) published a classi#ication of pneumococci 
and Lister (3) independently reported shortly afterwards a similar  classification 
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of  the  pneumococci  encountered  in  South  Africa.  Lister  then  undertook  an 
experimental  study  of  prophylactic  inoculation  against  the  various  types  of 
pneumococci in animals  and man.  He demonstrated that immunity can be pro- 
duced in man against at least certain ones of these types either by subcutaneous 
or intravenous injection, more readily by the latter.  He found that subcutaneous 
inoculation of 40 billion cocci of the strains he employed caused little if any  toxic 
reaction in  the  guinea  pig,  rabbit,  or man,  and  intravenous  inoculation of 20 
billion in the rabbit and 40 billion in man gave rise to but slight toxic reaction. 
On the basis of these experiments Lister undertook the prophylactic inoculation 
of large groups of miners  against pneumococcus and  has recently reported the 
results of his experiments.  He at first advocated inoculation at 7 day intervals, 
each dose to consist of  6 billion cocci of  each type against which immunity was 
desired.  Subsequently he greatly reduced this dosage and gave three subcutane- 
ous inoculations at 7 day intervals, each injection consisting of 2 billion of each 
type. 
The workers in three different mines, the Crown,  Premier Diamond,  and De 
Beers Diamond, were inoculated with a  vaccine composed of the three types of 
pneumococcus which were most prevalent in these mines.  They were known as 
Types A, B, and C.  Types B  and C correspond to Types II and I, respectively, 
in Dochez and  Gillespie's classification.  Type A  has  not  been  encountered in 
America.  In the De Beers Diamond Mine  a  fourth  group  was  added,  called 
Type H.  In the De Beers experiment 1 billion of Type H  was added to each in- 
jection, making a total dosage  at  each  injection  of 7  billion.  The  vaccinated 
miners were then observed over a  period of 6 to 12 months and in all three mines 
a  definite  decrease in  the  incidence  and  mortality  rate  from  pneumonia  was 
observed.  In the case of the Crown Mines, every case of pneumonia which oc- 
curred among the vaccinated individuals was studied  bacteriologically and  the 
type of pneumococcus determined.  No  cases  of  the  types  against  which  the 
men had been vaccinated (Types A, B, and C) developed during the 9 months of 
observation.  Lister contends that this fact, namely the alteration of a  relative 
group prevalence by means of specific group inoculation,  is  a  more  critical test 
of the efficacy of pneumonia  prophylaxis than  the  simultaneous  comparison  of 
pneumonia rates in inoculated and uninoculated (control) groups when the com- 
parison is based upon the erroneous assumption that all cases of disease  due  to 
the  pneumococcus  are bacteriologically indistinguishable.  He  emphasizes  the 
probability that the protection of a  considerable part of the community by in- 
oculation lessens the number  of carriers, and perhaps the virulence of the strains 
found in the community, and hence confers a  definite benefit upon the uninocu- 
lated group which would affect the use of this group  as controls in  a  statistical 
sense.  Lister  reported no unpleasant  effects from the vaccine. 
Bacteriological study  of  the  first  hundred  cases  of pneumonia  oc- 
curring at Camp Upton showed that about 70 per cent were due to the 
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I, II, or III.  In consideration of this fact and of the results achieved 
by Lister in South Africa, it seemed desirable to employ prophylactic 
vaccination against  the pneumococcus at Camp Upton.  At the out- 
set  it  was decided  to  incorporate  only  Types  I,  II,  and  III  in  the 
vaccine.  Vaccination against Type IV was obviously not feasible on 
account  of its many varieties.  The  preliminary  problems to be de- 
termined  were:  First,  how  large  a  dose of  such  a  vaccine  could be 
administered  without  producing  a  severe  reaction?  Second,  would 
the  dose,  injected  three  or  four  times  subcutaneously,  produce  an 
efficient and  demonstrable  immunity? 
Preliminary Experiments. 
For the preparation of the vaccine preliminary experiments showed 
that agar media were unsatisfactory because of the small yield of or- 
ganisms.  Experiments  in  immunizing  rabbits  with  pneumococci 
grown on a  variety of media indicated  that  those obtained  from 0.5 
per  cent  glucose  broth  were  as  effective  antigenically  as those ob- 
tained  from agar  media  or from plain  broth,  and  as  the  yield from 
glucose  broth  is  much  more  abundant  this  medium  was  adopted. 
To prevent  autolysis,  incubation  was  stopped  after  12  to  14  hours. 
Centrifuging was carried out by the use of a  continuous feed type of 
centrifuge  (Sharpless  laboratory  centrifuge)  which will take 8 to  12 
liters of broth per hour and give a clearer supernatant fluid than is usu- 
ally obtained from the bucket type of centrifuge.  The cultures were 
killed before centrifuging by heating to 53°C. for { hour.  This conserves 
the antigenic effects of the culture.  After centrifuging, the organisms 
were suspended in normal saline solution, shaken to secure even distri- 
bution, standardized by dilution and comparison of the  opacity with 
known  suspensions  of  pneumococci,  and  again  heated  at  55°C.  for 
½ hour.  Sterility of the  vaccine was established by aerobic and  an- 
aerobic  cultures  and  by  subcutaneous  inoculation  into  guinea  pigs 
and intraperitoneal  inoculation into mice.  Tricresol was added to a 
concentration of 0.3 per cent as a preservative. 
In order to determine the optimum dosage and interval of injection 
inoculations  were  given  to  forty-two  adult  volunteers  in  varying 
dosage  and  at  different  intervals,  and  the  effect  was  gauged  by 
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jection.  The character of the local and general reactions to the in- 
oculation was also  observed.  The  tests applied  to  the  serum were 
the agglutination titer against the three types included in the vaccine 
and  the  protective  power  of  the  sera  against  these  types injected 
into mice. 
The agglutination titer was carried out with 24  hour plain broth 
cultures of the same strains used in preparing the vaccine.  The serum 
dilutions  used  were  1: 1,  1: 3,  1: 10,  and  occasionally  1: 30.  The 
tubes were incubated for 2  hours at 37°C.  in a  water bath, given a 
first reading,  placed  in  the  ice  box  over night,  and  then  given the 
final  reading.  The results charted are based  on  the  final  reading. 
For  the protection experiments the method described by Dochez 
(4)  was employed.  A  plain broth passage  culture from the heart's 
blood of a mouse was used for each of the three strains employed in 
preparing the vaccine.  Several dilutions of these three cultures were 
made with sterile broth so that 0.5  cc. of the dilutions would contain 
respectively 0.01,  0.001,  0.0001,  0.00001,  and 0.000001  cc. of original 
culture.  2 parts of each serum were diluted with 3 parts of normal 
salt solution so that 0.5  cc. of the diluted serum contained 0.2  cc. of 
serum.  With each serum mice were injected intraperitoneally with 
some or  all  of the  following mixtures of diluted serum  and  diluted 
cultures. 
Mouse  1,  0.5 cc. of diluted culture (equals 0.01  cc. of culture of Type  I)  A- 0.5  cc.  of 
diluted serum. 
Mouse 2, 0.5  cc. of diluted culture  (equals 0.001  cc. of culture of Type I) -4- 0.5 cc. of 
diluted serum. 
Mouse 3, 0.5 cc. of diluted culture (equals 0.0001  cc. of culture of Type I) -{- 0.5 cc. of 
diluted serum. 
Mouse 4,  0.5  cc. of diluted culture  (equals 0.01  cc. of culture of Type II)  -b 0.5 cc. of 
diluted serum. 
Mouse 5, 0.5 cc. of diluted culture  (equals 0.001  cc. of culture of Type II) +  0.5 cc. of 
diluted serum. 
Mouse 6, 0.5 cc. of diluted culture (equals 0.0001  cc. of culture of Type II) +  0.5 cc. of 
diluted serum. 
Mouse 7, 0.5 cc. of diluted culture (equals 0.01  cc. of culture of Type III)+  0.5 cc. of 
diluted serum. 
Mouse 8, 0.5 cc. of diluted culture (equals 0.001  cc. of culture of Type III) -~ 0.5 cc. of 
diluted serum. 
Mouse 9, 0.5  cc. of diluted culture  (equals 0.0001  cc. of culture of Type III) -F 0.5 cc. 
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As  controls  six mice were injected  intraperitoneally  as follows: 
Mouse 1, 0.5 cc'. of diluted culture  (equals 0.00001  cc. of culture of Type I) +  0.5 cc. of 
normal saline solution. 
Mouse 2, 0.5  cc. of diluted culture  (equals 0.000001  cc. of culture of Type I)  -b 0.5  cc. 
of normal saline solution. 
Mouse 3, 0.5 cc. of diluted culture  (equals 0.00001  cc. of culture of Type II) +  0.5  cc. 
of normal saline solution. 
Mouse 4, 0.5 cc. of diluted culture  (equals 0.000~1  cc. of culture of Type II) +  0.5 cc. 
of normal saline solution. 
Mouse 5,  0.5 cc. of diluted culture  (equals 0.00001  cc. of culture of Type III)+  0.5 cc. 
of normal saline solution. 
Mouse 6,  0.5  cc.  of diluted culture  (equals 0.000001  cc.  of culture of Type  III)  q- 0.5 
cc.  of normal saline solution. 
The  time of injection  of  each  mouse  was  noted  and  the  number 
of hours  to  time  of  death  recorded.  When  a  mouse  had  survived 
over  140  hours  it  was  recorded  as  "survived."  Upon  dying  the 
mice  were  autopsied  and  films  made  from  the  peritoneal  exudate 
and  stained  to  determine  the presence  of  Gram-positive  diplococci. 
From  the  control mice,  upon  dying,  cultures  were  made from  the 
heart's blood and the type was verified by agglutination.  The range 
of  survival exhibited  in  the  controls  throughout  the  tests is  shown 
in Table  I. 
TABLE  I. 
Mouse  Controls  for Protection  Tests. 
Ty.._  ~_ I--  .  Type  II--  Type  III-- 
0.00001 cc.  0.000001 cc.  0.00001 cc.  0.000001 cc.[ 0.00001 cc.  0.000001  cc 
t 
M o mum  .............  28"  31  I  18  I  16  /  24  33 
Maximum ............  36  ]  36  ]  40  ]  32  ~  36  ]  45 
*The  figures indicate  the hours of survival  of each  mouse after injection. 
All inoculations except in Individual 9 were given subcutaneously. 
The  first  one  inoculated,  Individual  9,  received  two  subcutaneous 
inoculations  of  16  billion  cocci of  each  type  at  each  inoculation,  4 
days apart, followed 4 days later by, one-tenth this dose intravenously. 
An extensive area of redness with some tenderness followed the sub- 
cutaneous inoculations, reaching  the maximum in 48 hours but with- 
out incapacitating  the  subject;  there  was no  accompanying  general 24  PROPHYLACTIC  INOCULATION AGAINST  PNEUMOCOCCUS 
reaction.  The intravenous injection was followed 48 hours later by a 
slight malaise and a temperature of 100.4°F.  of a few hours' duration. 
All other inoculations were given subcutaneously as this was con- 
sidered the only method feasible for use later on a  large scale in the 
camp. 
Individuals 1 to 8 (Table II)received a first dose subcutaneously of 
8 billion cocci of each type.  In four adults a moderate local reaction 
resulted.  In  two,  however,  the  local  reaction  was  severe,  leading 
TABLE  II. 
Individuals  Receiving  a  Single  Large  Inoculation. 
1 
2 
3 
4 
5 
6 
7 
8 
Reaction. 
bi  ic 
8  Mod.  " 
8  "  " 
8  8  Sev.  S1. 
8  8  Mod.  Sev. 
8  Sev.  " 
8  8  Mod.  S1. 
8  8  S1.  Sev. 
Tests on Sera 7 days after injection. 
Agglutination,  Mouse protection. 
T) pe ] 
+ 
•  Type II.  Ty~.e  Type I. 
S. IS.  S. 
301103  " 
20  73  " 
18  29  5q 
301 S.  S. 
17  "  4: 
17  29  51 
20  39  S. 
Type n. 
¢~  "  ¢5 
2  S.  ! 
2  " 
2  " 
2  80  " 
lq  54  " 
1  80  " 
2  44  " 
Type III. 
25  37  S.52 
25[  261  57 
17  24  31 
,9f 27f s 
121  271  51 
10  511 S. 
241  291  43 
in  the  tables  N.  indicates  none,  Sl.,  slight,  Mod., 
and  Inf., infiltration.  The figures indicate  the hours  of 
after injection.  S. indicates  survival over 140  hours. 
moderate,  Sev.,  severe, 
survival of each mouse 
to  a  reddening and  swelling of  the  area  from the  shoulder  almost 
tothe wrist, persisting 3 days and rendering use of the arm during 
this time difficult.  In three adults a  chill with some nausea, marked 
malaise, and slight rise of temperature occurred in the first 24 hours. 
It was  concluded that reactions of this  type were  too  severe  to be 
permissible in a large scale vaccination.  A series of persons (Nos.  10 
to 21,  25,  and 27, Table III) was accordingly inoculated with four or 
five injections of much smaller doses at 3 to 7 day intervals (except RUSSELL  L.  CECIL  AND  J.  HAROLD  AUSTIN  25 
in two cases in which the interval between the first two doses was 2 
days).  Inasmuch  as  the  suggestion  had  been  made  that  Type III 
was  especially prone  to  induce  severe  local  reactions this  type was 
omitted from one of the inoculations in Individ~lals  10 to 16 and 27. 
No difference could be observed between the local reaction  in  these 
cases when Type III was omitted.  The  dosage used in Individuals 
12  to 16 was as follows: 
o of  i Noof  /  Day.  billions of Type  billions of Type n. No. of billio  of Type In 
1  1  1 
4  2  2 
7  4  4 
13  6  6 
The dosage of each type in other individuals was as follows: Indi- 
vidual 17: first injection  1 billion; second injection 2 billion; third in- 
jection  3  billion;  fourth  injection  4  billion.  Individuals  18  and  20: 
first injection  1 billion;  second injection  2  billion;  third  injection  2 
billion; fourth injection 3 billion.  Individuals  19 and 21: first injec- 
tion  1  billion;  second,  third,  and  fourth  injections  each  2  billion. 
Individual  25 received only half as much of Type III as of Types I 
and  II at each injection.  Of these fourteen adults, marked  local re- 
actions occurred after at least one of the inoculations in four instances 
but not severe enough to incapacitate the individual.  In none of these 
instances  was  there  any  severe  general  reaction.  These  doses  ap- 
peared to be such as could be satisfactorily employed on a large scale 
without unduly incommoding  a  command.  Still  smaller  doses were 
employed in Individuals 32, 33, 36, 37, and 38.  These were without 
any severe local reactions and with moderate or no general reaction. 
The experimental work of Cole and Moore (5)  showed that in rab- 
bits an immunity  could be more rapidly induced by small daily in- 
travenous  inoculations  of antigen  than  by much  larger  intravenous 
inoculations  at  longer  intervals.  To  test  the  applicability  of  this 
principle  to  subcutaneous  injections  in  man,  four  adults  (Nos.  39 
to 42)  were given daily subcutaneous injections of  1 billion  cocci of 
each type for 7 days.  These injections were associated with only the 
mildest  local  reactions  and  with  no  constitutional  reaction.  The ~o 
to 
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immune body response in the sera of these various groups is shown in 
Tables II and  III. 
From  sixteen persons  serum  was obtained before commencing  the 
vaccination.  In none of these was there any agglutinin demonstrable 
against any of the three types and in only one instance  (No. 9) were 
there any survivals in the mouse protection test, in this case against 
Type I.  On the other hand,  8 days after the vaccination agglutinins 
to some extent were demonstrable in twenty-seven of the forty-two in- 
dividuals studied and  a  definite degree of protective power as shown 
by the  survival of at least  some of the mice in all  of the  forty  cases 
in which the mouse protection test was performed. 
The degree of agglutinin production and of mouse protection varies 
so greatly in  the individual  cases in  any one group  that  it becomes 
difficult to draw positive deductions as to the merits  of the various 
methods  of administration  employed.  This  difficulty is indicated  if 
we group the persons according to dosage and number of inoculations 
and  tabulate  the  percentage  of positive agglutinations  at  each  titer 
and  of mouse  survivals  for  each  dose of  culture  for  these  groups. 
This we have done in Table IV.  From a  study of this table the con- 
clusion  seems justified  that  the  first group  (Adults  10  to  21)  which 
comprises  those  receiving  the  largest  total dosage exhibits definitely 
the  best  response  as  judged  by both  agglutination  and  the  mouse 
protection  test.  The  second group'(Adults  32,  33,  36,  37,  and  38) 
received  the  smallest  total  dosage  and  gave  definitely less  satisfac- 
tory  response.  A  comparison  of  the  third  group  (Adults  1  to  8), 
the  fourth group  (Adults  18  to 21,  25,  and  27),  and  the fifth group 
(Adults 39 to 42), all receiving practically the same total dosage but 
in the third  group given in a  single large dose, in the fourth in three 
or  four moderate  doses at  3  to  7  day intervals,  and  in  the  fifth  in 
seven very small daily doses, shows no definite difference that can be 
detected in  the  response of the  three  groups.  The  conclusions that 
we  draw  from  thes~  experiments  are  that  the  immune  response  as 
measured  by these  tests will depend on  the  total dosage  of vaccine 
and is little influenced by the number of doses into which this quan- 
tity is divided.  The  difference in  toxic reaction,  however,  in  these 
three  groups was definite.  The  small  daily  doses  gave  hardly  any 
reaction.  The single very large dose gave rise to several severe local 
and  constitutional  reactions. RUSSELL  L.  CECIL AND  J.  HAROLD AUSTIN 
TABLE  IV. 
Summary by Percentages of Agglutination and Protection  Tests in Sera. 
29 
Group. 
Group 1" (Individuals 10 to 21) ..... 
"  2  (  "  32, 33, and 36 
to 38) ....................... 
Group 3 (Individuals 1 to 8) .... 
4  (  "  18  to 21,--2'5," 
and 27) ...................... 
Group 5 (Individuals 39 to 42) ...... 
"  6 (  "  22  "  24, 26, 
28 to 31, 34, and 35) ........... 
Percentage of positive 
agglutinm reactions. 
Type I.  Type I]. 
I 
Percentage of mouse survivals 
in protection  test. 
Type l,  Type II.  [.~ 
~  per  per 
~ent  cent 
67  75 
40  20 
25 
50  50 
0  25 
67  44 
per  per  per  per 
cene  cent  cenll  cent 
33  58  58  17 
C  20  20  0 
C  62  0 
0  33  33  0 
25  25  25  C 
04422  11 
per  per  per  per  per  per  per 
cent  ~ent cent  cent  cent  cent  cenl 
12  54  82  lg  60  82  18 
0  25  75  C  25  75  25 
12  37  62  C  50100  37 
0  40  40  0  25100  0 
0  50  50  C  67  75  0 
11  40  90  10,  50  70  20 
* Group 1 received a  total dosage of from 7 to  13 billion cocci of each type. 
Group 2 received a total dosage of from 2½ to 4 billion cocci of each type.  Groups 
3, 4, and 5 received a total dosage of from 7 to 9 billion cocci of each type, Group 
3 in a single large injection, Group 4 in three or four moderate injections at 3 to 
7 day intervals, and Group 5 in seven small daily injections.  Group 6 received 
a total dosage of 3 to 6 billion cocci of each type and developed infiltrations. 
Vaccinations  of  Troo'ps. 
On the basis of  these preliminary experiments we  adopted for  the 
larger  scale  vaccinations a  moderate  total  dosage  of  6  to  9  billion 
cocci of each type and administered this in four small doses at weekly 
intervals.  By this method we  expected to  secure a  definite immune 
response in the vaccinated individuals with a  minimum of  severe re- 
actions and without  undertaking a  larger number  of injections than 
would  be  within  the  capacity  of  the  medical  staff  of  the  camp  to 
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The  detailed  dosage  decided  upon was: 
1st  inoculation:  Pneumococcus Type I  1  billion 
"  "  II  1  " 
"  "  III  1  " 
Total ........  3  " 
2nd inoculation:  Pneumococcus  Type I  2  billion 
"  "  II  2  " 
"  "  III  2  " 
Total ........  6  " 
3rd inoculation:  Pneumococcus  Type I  3  billion 
"  "  II  3  " 
"  "  III  1½  " 
Total ........  7½  " 
4th  inoculation:  Same  as 3rd inoculation. 
The vaccine was made up in three different concentrations  so that 
the  dose in  every case was 0.5  cc. 
Altogether,  12,519  men were vaccinated,  about  40 per  cent  of the 
mean strength  of the  command.  A  great majority of these received 
three  or four  inoculations.  Some,  however,  had  only  one  or  two. 
The vaccine was given at 5  to  7 day intervals,  except in one organi- 
zation  where  unavoidable  circumstances  necessitated  a  lapse  of  20 
days  between  the  first  and  second  inoculations.  In  most  cases  the 
vaccine was administered in the arm. 
Reactions. 
The constitutional reactions to the pneumococcus inoculations were 
usually  negligible.  Out  of  the  entire  number  vaccinated,  only 
twenty-five  men  were  sufficiently  ill  to  remain  in  quarters  or  the 
hospital  for  a  short  time.  This  number  would  probably have been 
larger if the vaccination had been compulsory.  As it was, those who 
were upset by the  first or second  inoculation  were usually  not  given 
the third or fourth.  The impression prevailed among the regimental 
surgeons that the reactions to pneumococcus vaccination were milder 
than  those  to  typhoid  vaccination.  The  troops,  however,  were  in 
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cine  than when  the  typhoid  inoculations  were given.  In those  who 
reacted  severely  the  symptoms  simulated  an  attack  of  influenza. 
The  patient  complained  of  general  malaise,  chilly  sensations, fever, 
and  muscular  pains.  In  addition,  a  certain  number  of  those who 
reacted  severely  had  symptoms  referrable  to  the  upper  respiratory 
tract,  such  as  coryza,  sore throat,  cough,  and  pain in  the  chest.  A 
number  of  those  who  were  sufferiflg  from infections of the  air pas- 
sages at  the  time  of inoculation,  claimed  that  their  symptoms  were 
TABLE  V. 
Incidence  of Infiltrations  and  General  Reactions  among  the  Vaccinated  Troops. 
Organization. 
305th Infantry  ........................... 
306th  " 
307th  " 
308th  " 
302nd Sanitary Train .................... 
367th Infantry (colored)  ..... ............. 
304th Machine Gun Battalion ............. 
305th  "  "  " 
306th  "  "  " 
302nd Engineers  ......................... 
Base Hospital ............................ 
Total ................................. 
No. vaccLnated 
(approximate). 
2,500 
2,800 
1,500 
2,150 
700 
1,500 
40O 
400 
500 
35 
25 
12,510 
Reactions. 
General reaction 
Infiltrations.  (quarters  or 
hospital). 
43  12 
62  6 
6  0 
28  5 
3  1 
1  0 
2  0 
4  1 
3  0 
0  0 
0  0 
152  25 
(1 in 82)  (1 in 500) 
more marked  after receiving  the  injection.  Constitutional  reactions 
to  pneumococcus  vaccination  apparently  develop  more  slowly  than 
with  typhoid  inoculation,  sometimes  not  appearing  until  24  hours 
after  the injection. 
The  local reaction  to  pneumococcus vaccination  differs little,  as  a 
rule,  from that  to  typhoid vaccination.  At the point of inoculation 
an area of tenderness  and induration  develops, usually about 5  to  10 
cm.  in  diameter.  The  area  of  induration  is  nearly  always  oblong 
and  extends  down  the  arm  below  the  point  of  inoculation.  The 
axillary  glands  are  sometimes  swollen  and  tender.  The  tenderness 32  PROPHYLACTIC  INOCULATION  AGAINST  PNEUMOCOCCUS 
and  swelling  at  the point  of inoculation  rapidly  decrease,  however, 
and at the end of 3 or 4 days have usually disappeared. 
An unexpected  and  somewhat  troublesome  complication  arose  in 
connection  with  the  vaccination  which  at  first  gave  us  some  con- 
cern; this was the development of a  certain number of small infiltra- 
tions at the site of inoculation.  They developed slowly, rarely com- 
ing to the stage of fluctuation before the 6th or 7th day after inocu- 
lation.  In size they were usually 2 or 3 cm. in diameter, and in only 
one  instance  extended  down  deeper  than  the  subcutaneous  tissue. 
A~/ first  they were looked upon  as  the  result  of  careless  technique, 
but  repeated  cultures  showed  them  to  be invariably  sterile.  Some 
of them  developed after  the  first inoculation,  but a  greater  number 
followed the  larger  doses.  In  a  few cases an  infiltration  developed 
with  each  inoculation  given.  This  would have  probably happened 
more frequently had  the vaccination not been discontinued  in  those 
who  developed  the  condition after the first or second dose.  At first 
the regimental surgeons made an incision, but later it was found that 
the infiltrations would progress favorably if left alone.  Altogether, 152 
men developed the lesion (1 in every 82, Table V).  They were fairly 
evenly distributed  throughout  the  various organizations  vaccinated, 
with the exception of the 1,500 vaccinated negroes, among whom only 
one developed.  The infiltrations were tender and painful in the early 
stage  of  their  development  but  later  became  cold  and  painless. 
They apparently developed from a hypersensitiveness to the pneumo- 
coccus  or  pneumotoxin.  In  the hope of discovering whether  these 
individuals  exhibited  a  more  or  less  marked  immune  response  in 
their  sera,  the  sera  of  ten  such  persons  were  studied  (Table  III, 
Adults 22 to 24, 26, 28  to  31,  34,  and  35).  The  percentile  results 
are  tabulated  in  Table  IV  as  Group  6.  Apparently  the  immune 
response in this  group is analogous to that  of  the  other  individuals 
receiving  the  same  total  dose  of  vaccine.  We  would  conclude, 
therefore,  that  there  is  no  demonstrable  difference  in  the degree of 
immune response by the tests we have  used  in  individuals  showing 
pronounced  local  reaction  even  to  the  extent  of  local  infiltration 
described.  Few  of  the  men  responding  in  this  way had  ever  had 
pneumonia.  With  only one exception they did not occur among  the 
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are  not related  in  any way to  the method  of  administration  of the 
vaccine. 
In  order  to  test  the  relation  of  these  severe reactions  to  the  sus- 
ceptibility  to  pneumotoxin,  the  following  experiments  were  per- 
formed.  Pneumotoxin  was  prepared  by  Cole's  (6)  method,  which 
consists  of growing  pneumococci  in  plain  broth;  centrifuging  and 
washing  in  normal  saline  solution;  solution  of  the  pneunlococci in 
~veak  sodium  taurocholate  solution  at  37°C.;  dilution  to  one-tenth 
the  bulk  of  the  original  broth  culture.  This  pneumotoxin  was  di- 
luted 1:10 with normal saline solution and injected intradermally  to 
the  amount  of 0.1  cc.  in  a  series  of  healthy  volunteers.  Little  re- 
sulting  reaction  was noted  in  most individuals.  However, in  those 
who had  shown severe local reactions  to  the vaccination  or had  de- 
veloped infiltrations,  an  extensive  areola  developed about the pneu- 
motoxin injection,  reaching  the maximum after about 24 to 36 hours 
and  often  being  associated  with  considerable  tenderness.  The  re- 
action to the pneumotoxin occurred regardless of the type used in its 
preparation,  exhibiting  no  specificity for  type.  These  findings  sug- 
gest  that  the  severe  local  reactions  to  the  vaccine  are  due  to  an 
unusual  sensitiveness to  a  pneumotoxin  which  is common  to all  the 
types of pneumococci. 
Table V  shows the number of men vaccinated in each organization 
and the incidence of infiltrations and severe general reactions in each. 
Bacteriological Examination  of Sputa. 
Particular  attention  was  directed  to  the  bacteriological  examina- 
tion of the sputum in the cases of pneumonia  that developed during 
the  period  of  observation.  In  seven  instances  this  examination, 
through  some unavoidable circumstance,  was not  completed.  In  all 
the others,  however, the sputum was examined and the predominant 
organism  determined. 
The Avery blood broth method  (7) was used  in  a  great  majority 
of  cases and  in  addition,  whenever it was possible,  a  mouse was in- 
oculated,  or  a  direct  culture  from  sputum  was  made  on  a  blood 
agar plate.  The  following figures indicate  the number of times each 
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1.  Both  mouse and  blood broth ...................................  47 
2.  "  blood broth  and  direct culture ...........................  23 
3.  Blood  broth  alone ...........................................  108 
4.  Mouse  alone ................................................  5 
Results of Vaccination. 
The  vaccination  of  the  troops began  on  February  4,  1918.  The 
Divisior~ was  transferred  from  Camp  Upton  about  April  15,  1918. 
The following figures are based on the period extending from Febru- 
ary  4  to  April  15,  about  10  weeks.  The  number  of  troops  vacci- 
nated was 12,519.  The number of unvaccinated was approximately 
19,481.  The latter figure varied,  of course, from day to day as new 
men came and others departed.  The vaccinated men were in stable 
organizations  where the personnel underwent little  change. 
Before discussing the results of vaccination, it is of interest to note 
the incidence of pneumonia  previous to the beginning of vaccination 
in the various organizations  which later  received the vaccine and  to 
compare  this  with  the  incidence  of  pneumonia  at  the  same  period 
among  the  organizations  which  did  not  later  receive  the  vaccine. 
Previous  to  February  4,  the  day  on  which  the  experiment  began, 
there  had  been  91  cases of pneumonia  among  the  troops  at  Camp 
Upton.  Of these,  29  occurred among  the  organizations  which were 
subsequently  vaccinated,  while  43  cases  occurred  among  the  units 
which were later  to be used as a  control;  19 occurred among casuals 
not included later in either group.  It will be seen from this that the 
cases  of  pneumonia  were  quite  evenly  divided  between  the  40  per 
cent of the  troops which were to be vaccinated  and  the 60 per cent 
which were to be used for controls.  Of the 29 pneumonias occurring 
among  the  organizations  which  were  subsequently  vaccinated,  9 
were due  to pneumococci of Type I,  II, or III and  11  to  Pneumo- 
coccus Type IV.  Of the 43 pneumonias occurring among the control 
group,  16 were due to pneumococci of Type I,  II,  or  III  and  17  to 
Pneumococcus Type IV. 
Furthermore,  about  30  per  cent  of  all  these  pneumonias  wcre 
streptococcus  cases  and  these,  too,  were  fairly  equally  divided  be- 
tween the  two groups  of organizations,  9  occurring  among  the  men 
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Incidence of Pneumonia among the Vaccinated Troops from February 
4 to April 15,  1918.--There  has been but one case of pneumonia due 
to pneumococcus of Type I, II,  ot III among  the  vaccinated troops 
during  this  period.  This  case,  due  to  Type  I  pneumococcus,  de- 
veloped 24  hours  after  the  first  inoculation  and  therefore  before 
protection  could have  been  developed.  During  this  period  sixteen 
cases  of  other  types  of  pneumonia  occurred  among  the  vaccinated 
troops  (Table VI).  There  were nine  Type IV pneumococcus cases; 
three of these had only received one injection of vaccine.  The remain- 
ing seven cases were streptococcus infections, six due to the hemolytic 
streptococcus, and one to Streptococcus  viridans.  None of the pneu- 
mococcus cases died.  The  Type I  case received Type I  serum  and 
TABLE  VI. 
Incidence of Pneumonia among the Vaccinated Troops, February 4 to April 15, 1918. 
Average strength of command, Feb. 4  to Apr. 15, 1918 ............  32,000 
No. of troops vaccinated against pneumonia .....................  12,519  (40 per cent) 
"  "  unvaccinated men (average) .............................  19,481  (60  "  "  ) 
Incidence of pneumonia among the vaccinated troops, Feb. 4  to Apr.  15: 
Pneumococcus Type I  (developed 24 hrs. after 1st injection) .......................  1 
"  "  IV (3 cases receiving only 1 injection) .........................  9 
Streptococcus  hcemolylicus ......................................................  6 
"  viridans .........................................................  1 
Total No. of pneumonias among the vaccinated troops .......................  17 
made an uneventful recovery.  Most of the Type IV cases ran a mild 
course, so  mild  in  some  cases  that  the  diagnosis of pneumonia  was 
made  only by the  aid of the x-ray.  Two of the streptococcus cases 
died,  both being of the hemolytic group. 
Incidence  of Pneumonia  among  the  Unvaccinated  Troops from Feb- 
ruary  4  to April  15,  1918.--The  unvaccinated  fraction  of  the  camp 
has been divided into two groups  (Table VII).  First,  the old troops 
whose physical condition and resistance to infection were presumably 
the same as that of the vaccinated men.  They constituted, numeri- 
cally, about 75 per cent of the controls.  Second, the new troops who 
consisted of newly drafted men coming into camp between February 
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ably  more  susceptible  to  infection  than  the  seasoned  troops.  These 
comprised  about  25  per  cent  of  the  controls.  Among  the  old  troops 
there  were  eighteen  cases  of  pneumonia  due  to  Pneumococcus  Type 
I,  II,  or  III,  and  seventeen  cases due  to Type  IV, making  a  total  of 
TABLE  VII. 
InciAence  of  Pneumonia  among  the  Unvaccinated  Troops,  February  4  to  April  15, 
1918. 
Type of pneumonia.  No. of ca~s of pneumonia 
Old troops (75 per cent of control). 
Pneumococcus Type I .................................. 
"  "  II .................................. 
"  "  III  ................................ 
"  "  IV ................................. 
Streptococcus  htemolyticus  ................................ 
"  viridans  ................................... 
B.  influenzce  ........................................... 
Type undetermined .................................... 
Total ........................................... 
sl 
5/ 
sJ  t 3s 
17  17J 
23  68 
1 
6 
110 
New drafted  men,  Feb.  26  to Apr.  15  (25  per cent of control). 
Pneumococcus Type I ................................. 
"  "  II ................................. 
"  "  III  ................................ 
"  "  IV ................................ 
Streptococcus  tutmolyticus  .....................  .......... 
"  viridans  .................................. 
Type undetermined .................................... 
Total ........................................... 
81  2J  24 
16  16J 
27}  38 
ll 
1 
63 
Total No. of Type I, II, and III pneumonias among the unvaccinated troops .......  26 
"  "  "  "  I, II, III, and IV  "  "  "  "  "  .......  59 
"  "  "  streptococcus pneumonias among the unvaccinated troops ............  106 
"  "  "  pneumonias among the unvaccinated troops ........................  173 
thirty-five  cases  of  pneumococcus  pneumonia.  There  were  sixty- 
eight streptococcus  cases, forty-five of the hemolytic  type and  twenty- 
three  of the  non-hemolyzing  type.  There  was one  Bacillus  influenz6e 
case  and  six  cases  in  which  the  type  was  not  determined. RUSSELL L.  CECIL AND  J.  HAROLD AUSTIN  37 
Among  the  new men the proportion was  about  the  same.  There 
were eight cases due to Pneumococcus Type I, II, or III.  There were 
sixteen  cases  of pneumonia  due to Pneumococcus Type IV,  making 
twenty-four cases  of pneumococcus pneumonia.  There were thirty- 
eight cases of streptococcus pneumonia, twenty-seven of the hemolytic 
type and eleven of the non-hemolyzing type.  There was  one case in 
which the organism  was not determined. 
TABLE VIII. 
Mortality  Rates. 
Type of pneumonia.  Deaths. 
Among unvaccinated troops. 
Pneumococcus. 
Types I, II, and III ............................................  7 
Type IV ......................................................  6 
Streptococcus  hcemolytlcus  ............................................  26 
"  viridans  ............................................... 
Type undetermined  ............................................... 
Total ..............................................  : ........  48 
Annual pneumonia death rate per 1,000 for unvaccinated troops  .........  12.8 
per Cent 
27 
18 
36 
12 
28 
Among vaccinated troops. 
Pneumococcus  ....................................................  i  i 
Streptococcus  h¢molyticus  ........................................... 
"  viridans  ....  .  ..................................  ....... 
Total  ......................................................  per  ..........  '  8 
Annual pneumonia death rate  1,000 for vaccinated troops  [I 0.3  I1 
11.7 
A  summary of the  control shows  that  there were  twenty-six cases 
of pneumococcus pneumonia of Type I, II, or III.  There were thirty- 
three  Pneumococcus  Type  IV  cases,  making  a  total  of  fifty-nine 
pneumococcus  pneumonias.  There was  a  total of 106  streptococcus 
pneumonias,  72  of  which  were of the hemolytic type and 34  of the 
viridans,  or  non-hemolyzing type.  Altogether there were 173  pneu- 
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There  were seven deaths among the Pneumococcus Type I, II, and 
III cases, or 27 per cent (Table VIII).  There were six deaths among 
the  Pneumococcus Type IV  cases,  or  18  per  cent.  Of the  strepto- 
coccus  cases,  hemolytic  type,  twenty-six  died,  or  36  per  cent. 
There were only four deaths, among the viridans cases, the mortality 
being  12 per cent. 
DISCUSSION. 
The  first  and  most  important  deduction  to  be  made  from  these 
statistics  is  that  pneumococcus pneumonia  of Types I,  II,  and  III 
has  not  occurred  among  the  vaccinated  troops,  whereas  twenty-six 
cases have occurred among the unvaccinated part of the camp.  This 
is the best test of the value of the vaccination as a prophylactic meas- 
ure.  The  one  case  of Type I  pneumonia  that  developed ,24  hours 
after  the  patient  had  received his  first inoculation may properly be 
excluded from among the vaccinated cases, as the patient  was prob- 
ably already infected at the time he received the injection and could 
not have had time for the development of any appreciable immunity. 
As Lister pointed  out,  the diminution  or disappearance  of certain 
types of pneumoni  a as the result of specific type inoculation is a more 
critical  test of the  efficacy of pneumonia prophylaxis  than  the mere 
simultaneous  comparison  of pneumonia  rates  in vaccinated  and  un- 
vaccinated groups.  It is true that  the period of  observation  in  this 
experiment  has been short,  but the immunity,produced  by the  vac- 
cine  appears  to  have  been  adequate  for  this  period  of  time.  How 
much longer  this immunity will  last  can only be determined  by fol- 
lowing  these men  and studying  the  cases of pneumonia  that  subse- 
quently develop among  them. 
There have been only six cases of Pneumococcus Type IV pneumonia 
among  the men who received two or more'injections  of the vaccine, 
while  the  control column shows thirty-three  cases among~ the unvac- 
cinated  troops.  The marked  difference in these figures and the mild 
course which the Pneumococcus Type IV pneumonias ran in the vac- 
cir)ated  series might suggest that some cross-protection against  Type 
IV pneumococcus has been afforded by the Type I, II, and III vaccine. 
This  theory,  however,  is  hardly  admissible  when  ~ve note  that  the 
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in  the  vaccinated  and  the  unvaccinated  troops.  There  were  106 
cases  of  streptococcus pneumonia  among  the  unvaccinated troops, 
whereas  there were only seven streptococcus pneumonias among the 
vaccinated troops.  Among the 3,500 colored troops, half the companies 
were vaccinated against pneumonia, the other half were not.  There 
were  twenty-eight  cases  of  streptococcus  pneumonia  among  the 
unvaccinated half  and  only two  cases  of  streptococcus pneumonia 
among the vaccinated half, yet these men were living in the same part 
of the camp and closely associated on drill-grounds, and il~ recreation 
and amusement hails. 
We have no explanation to offer for this difference.  That an epi- 
demic  of  streptococcus  pneumonia  occurred  at  about  this  time  in 
the  camp,  there  can be  no  question.  Not  only  the bacteriological 
studies, but the clinical course, the frequency of empyema, the mor- 
tality rate,  and  the  character of the  autopsy  findings  confirm  the 
bacteriological diagnosis.  Why this  epidemic should  to  a  large ex- 
tent have spared  the vaccinated  troops  cannot be  explained.  The 
incidence of pneumonias, pneumococcic  and streptococcic, was approxi- 
mately equally distributed  in  the two  groups  of organizations pre- 
vious to the beginning of the vaccination.  While no explanation of 
this phenomenon can be offered, it presents no argument against the 
use of prophylactic vaccination against the pneumococcus,  nor  does 
it in the slightest degree weaken the importance of the fact that while 
twenty-six  cases  of  Type  I,  II,  or  III  pneumococcus pneumonia 
occurred among the unvaccinated, none occurred among the vacci- 
nated  troops.  While  it  is  still  too  early  to  draw  final  conclusions 
from  this  experiment,  we  feel  that  the  results  are  sufficiently en- 
couraging to  justify further investigation along these lines. 
SUMMARY. 
1.  From  a  study of the  agglutinins  and protective power  of the 
serum of 42 persons vaccinated against the pneumococcus, Types I, 
II,  and III, it is demonstrated that a  definite immune response has 
been secured to  Types I  and  II  l~y the dose of vaccine employed. 
Little evidence of response to Type III can be demonstrated by these 
methods, but this is of less significance in that in animals it is rela- 40  PROPHYLACTIC  INOCULATION  AGAINST  PNEUMOCOCCUS 
tively  difficult  to  secure  antibodies  against this strain in the  serum, 
even  though  a  considerable  degree  of  active  immunity  may  have 
been produced in the vaccinated animal. 
2.  The  degree  of  response  to  the  vaccination  appears  to  be  de- 
pendent upon  the  total dosage of each type of pneumococcus admin- 
istered.  While  some  response  may  be  elicited  by 2½  billion  cocci 
of each  type, a  much more  constant  and greater response follows 13 
billion. 
3.  In  subcutaneous  administration  the manner  in which the total 
dosage is divided, whether given in a  single large dose, in seven small 
daily doses, or in  three  to five moderate  doses at  3  to  7  day inter- 
vals,  seems  to  have  little  influence  upon  the  degree  of immune  re- 
sponse , provided the total dosage is the same. 
4.  The  local and  general  toxic reaction  varies  greatly  in different 
individuals.  The  smaller  the  individual  doses,  the  fewer  are  the 
severe reactions.  This makes it desirable to divide the total dosage 
into  as many inoculations  as circumstances make practicable. 
5.  At  Camp  Upton  12,519  men  have  been  vaccinated  against 
Pneumococcus Types I, II, and III.  Three or four doses were given 
at intervals  of 5  to  7 days with a  total  dosage  of 6  to 9  billion  of 
Types I  and II and 4½ to 6 billion of Type III. 
6.  During the 10 weeks that have elapsed since the vaccination, no 
cases  of  pneumonia  of  these  three  types have  occurred  among  the 
men who had received two or more injections of vaccine. 
7.  In  a  control  of  approximately  20,000  men  there  were  twenty- 
six  cases  of  Pneumococcus Types I,  II,  and III pneumonias during 
the  same period. 
8.  The incidence of Pneumococcus Type IV pneumonia and strep- 
tococcus  pneumonia  was  much  less  among  the  vaccinated  troops 
than  among  the  unvaccinated.  No  explanation  has been advanced 
for  this  difference. 
9.  Small  sterile  infiltrations  disappearing spontaneously occasion- 
ally  follow  the injection of large doses of pneumococcus vaccine and 
appear  to be an  expression  of cutaneous hypersusceptibility. 
10.  The  persons  who develop these  lesions  exhibit  local  reactions 
to each dose of vaccine.  They also give abnormally marked reactions 
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exhibit  anything notable  in  the  agglutinative  or  protective  powers 
of  their  sera  after  vaccination.  Whereas  the  immune  response  is 
characteristically specific for the type of pneumococcus, this reaction 
is not specific for any type.  We have found no evidence that Type 
III is more prone to elicit these severe local reactions than are Types 
I  and  II. 
11.  Prophylactic vaccination against pneumococcus of Types I, II, 
and III is practical and apparently gives protection against pneumonia 
produced by these types.  It remains to be determined how long this 
immunity persists. 
This  investigation  has  been  made  possible  through  the  constant 
support  and assistance of Lieutenant-Colonel C.  R.  Reynolds of the 
Medical Corps, U.  S.  Army, to whom we are greatly indebted. 
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